Purpose: The last decade has witnessed an unprecedented growth in glaucoma treatment
options through the introduction of minimally invasive glaucoma surgeries (MIGS). The aim …

Despite advances in surgical technique and postoperative care, fibrosis remains the major
impediment to a marked reduction of intraocular pressure without the need of additional …

The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the
treatment of neovascular age-related macular degeneration one decade ago marked the …

The current literature continues to support the use of trabeculectomy as a method of
lowering intraocular pressure in glaucoma management. Efficacy has been improved by …

Background Trabeculectomy is performed as a treatment for glaucoma to lower intraocular
pressure (IOP). The surgical procedure involves creating a channel through the wall of the …

A number of antivascular endothelial growth factor agents are currently available to treat
various ocular conditions. These agents have similar, but distinct, biologic qualities and …

Abstracts Purpose: Pirfenidone is mostly used in antifibrotic and anti-inflammatory therapies.
We have previously demonstrated that pirfenidone had antifibrotic and anti-inflammatory …

Introduction Trabeculectomy is the most commonly performed surgery for the definitive
treatment of glaucoma. Despite its high resolvability, the postoperative period requires high …

Purpose Reintervention rate is an important factor impacting on patients, surgeons, and
society. To date, only a few studies have focused on this topic. For this reason, a systematic …

AIM To compare the effectiveness of postoperative adjunctive use of subconjunctival
bevacizumab in altering the outcome of primary trabeculectomy in terms of sustained …